Tom Claeys

email

TomW.Claeys@UGent.be

1 – 24 of 24

show: 100
|
sort: year (new to old)

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/person/000060122418?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

2018
- A1
- journalArticle
Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction
Sarah Buelens UGent, Tom Claeys, Bert Dhondt UGent, Filip Poelaert UGent, Matthijs Vynck UGent, Nurten Yigit UGent, Olivier Thas UGent, Piet Ost UGent, Jo Vandesompele UGent, Nicolaas Lumen UGent, et al. (2018) CLINICAL GENITOURINARY CANCER. Mark
- C3
- conference
Reproduceerbare isolatie van hoog-zuivere urinaire extracellulaire vesikels voor uro-oncologische biomerkerstudies
Bert Dhondt UGent, Glenn Vergauwen UGent, Jan Van Deun UGent, Edward Geeurickx UGent, Joeri Tulkens UGent, Lien Lippens UGent, Sarah Buelens UGent, Elise De Bleser UGent, Filip Poelaert UGent, Tom Claeys, et al. (2018) Elautprijs, Samenvattingen. Mark
- C3
- conference
Multicentrische prospectieve Lokale behandeling van Metastatische Prostaatkanker (LoMP) studie : interim analyse van de klinische uitkomsten en prognostische factoren
Sarah Buelens UGent, Filip Poelaert UGent, Bert Dhondt UGent, Elise De Bleser UGent, Tom Claeys, CAROLINE VERBAEYS UGent, Bernard Rappe UGent, Bart Kimpe, Ignace Billiet, Hendrik Plancke, et al. (2018) Elautprijs, Samenvattingen. Mark
- C3
- conference
Multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial : interim analysis of clinical outcomes and prognostic factors
Sarah Buelens UGent, Filip Poelaert UGent, Bert Dhondt UGent, Elise De Bleser UGent, Tom Claeys, CAROLINE VERBAEYS UGent, Bernard Rappe UGent, Bart Kimpe, Ignace Billiet, Hendrik Plancke, et al. (2018) OncoPoint, 6th Research seminar, Abstracts. Mark
- A1
- journalArticle
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
Piet Ost UGent, Dries Reynders UGent, Karel Decaestecker UGent, Valerie Fonteyne UGent, Nicolaas Lumen UGent, Aurélie De Bruycker, Bieke Lambert UGent, Louke Delrue, Renée Bultijnck UGent, Tom Claeys, et al. (2018) JOURNAL OF CLINICAL ONCOLOGY. Mark
- U
- journalArticle
Genitoplasty in newborn females with adrenogenital syndrome: Focus on the reconstruction technique and its outcomes
Marjan Waterloos UGent, Tom Claeys, Maxime Sempels, Erik Van Laecke UGent, Piet Hoebeke UGent and Anne-Françoise Spinoit UGent (2018) Journal of Pediatric Urology. 14(2). Mark
2017
- A1
- journalArticle
Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer
Filip Poelaert UGent, Candy Kumps, Nicolaas Lumen UGent, Stéphanie Verschuere, Louis Libbrecht, Marleen Praet, Sylvie Rottey UGent, Tom Claeys, Piet Ost UGent, Karel Decaestecker UGent, et al. (2017) UROLOGIA INTERNATIONALIS. 99(2). p.222-228 Mark
- C3
- conference
Purification of urinary extracellular vesicles for uro-oncological biomarker studies using an iodixanol (Optiprep™) density gradient
Bert Dhondt UGent, Glenn Vergauwen UGent, Jan Van Deun UGent, Edward Geeurickx UGent, Tom Claeys, Filip Poelaert UGent, Sarah Buelens UGent, An Hendrix UGent, Olivier De Wever UGent and Nicolaas Lumen UGent (2017) EUROPEAN UROLOGY SUPPLEMENTS. 16(3). p.e1078-e1079 Mark
- C3
- conference
Purification of urinary extracellular vesicles for uro-oncological biomarker studies using an iodixanol (OptiprepTM) density gradient
Bert Dhondt UGent, Glenn Vergauwen UGent, Jan Van Deun UGent, Edward Geeurickx UGent, Tom Claeys, Filip Poelaert UGent, Sarah Buelens UGent, Nicolaas Lumen UGent, An Hendrix UGent and Olivier De Wever UGent (2017) OncoPoint, 5th Research seminar, Abstracts. Mark
- A1
- journalArticle
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
Tom Claeys, Nicolaas Lumen UGent, Candy Kumps, Marleen Praet, Gert De Meerleer UGent, Sylvie Rottey UGent, Piet Ost UGent, Pieter De Visschere, Geert Villeirs UGent, Valerie Fonteyne UGent, et al. (2017) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 35(4). p.152.e13-152.e22 Mark
- C3
- conference
Androgen receptor gene copy number detection using droplet digital PCR and its therapeutic consequences in prostate cancer patients
Sarah Buelens UGent, Tom Claeys, Candy Kumps, Bert Dhondt UGent, Filip Poelaert UGent, Nurten Yigit UGent, Matthijs Vynck UGent, Olivier Thas UGent, Piet Ost UGent, Jo Vandesompele UGent, et al. (2017) OncoPoint, 5th Research seminar, Abstracts. Mark
- C3
- conference
The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR
Sarah Buelens UGent, Tom Claeys, Candy Kumps, Bert Dhondt UGent, Filip Poelaert UGent, Y Nurten, Matthijs Vynck UGent, Olivier Thas UGent, Piet Ost UGent, Jo Vandesompele UGent, et al. (2017) EUROPEAN UROLOGY SUPPLEMENTS. 16(3). p.e842-e843 Mark
2016
- C3
- conference
Isolation of urinary extracellular vesicles for uro-oncological biomarker studies is complicated by Tamm-Horsfall protein
Bert Dhondt UGent, Delphine Daveloose, Glenn Vergauwen UGent, Jan Van Deun UGent, Edward Geeurickx UGent, Tom Claeys, Filip Poelaert UGent, An Hendrix UGent, Olivier De Wever UGent and Nicolaas Lumen UGent (2016) EUROPEAN UROLOGY SUPPLEMENTS. 15(13). p.e1633-e1634 Mark
- C3
- conference
Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors
Filip Poelaert UGent, VALERIE FONTEYNE, Tom Claeys, Piet Ost UGent, Karel Decaestecker UGent, Gert De Meerleer UGent, Bert Dhondt UGent, Pieter De Visschere and Nicolaas Lumen UGent (2016) EUROPEAN UROLOGY SUPPLEMENTS. 15(3). p.e680-e680 Mark
2015
- A1
- journalArticle
Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire
Julie Devos UGent, Charles Van Praet UGent, Karel Decaestecker UGent, Tom Claeys, VALERIE FONTEYNE, Veerle Decalf UGent, Gert De Meerleer UGent, Piet Ost UGent and Nicolaas Lumen UGent (2015) ACTA CLINICA BELGICA. 70(4). p.272-279 Mark
- A1
- journalArticle
Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome
Tom Claeys, Charles Van Praet UGent, Nicolaas Lumen UGent, Piet Ost UGent, VALERIE FONTEYNE, Gert De Meerleer UGent, Bieke Lambert UGent, Louke Delrue, Pieter De Visschere, Geert Villeirs UGent, et al. (2015) BIOMED RESEARCH INTERNATIONAL. Mark
- C3
- conference
Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study
Tom Claeys, Nicolaas Lumen UGent, Gilles Thuysbaert, Marleen Praet, Gert De Meerleer UGent, Sylvie Rottey UGent, Piet Ost UGent, Pieter De Visschere, Geert Villeirs UGent, VALERIE FONTEYNE, et al. (2015) EUROPEAN UROLOGY SUPPLEMENTS. 14(2). p.e728-e728a Mark
2014
- C3
- conference
Salvage pelvic lymph node dissection in prostate cancer: surgical and oncological outcome
Tom Claeys, Charles Van Praet UGent, Karel Decaestecker UGent, Piet Ost UGent, VALERIE FONTEYNE, Gert De Meerleer UGent, Pieter De Visschere, Geert Villeirs UGent and Nicolaas Lumen UGent (2014) EUROPEAN UROLOGY SUPPLEMENTS. 13(5). p.140-141 Mark
- C3
- conference
Daytime incontinence as unusual presentation of Transitional cell carcinoma of the bladder in a 14 years-old girl: case report
Anne-Françoise Spinoit UGent, Karel Decaestecker UGent, Bruno Bamelis, LUITZEN ALBERT GROEN, Erik Van Laecke UGent, Tom Claeys and Piet Hoebeke UGent (2014) AUSTRALIAN AND NEW ZEALAND CONTINENCE JOURNAL. 20(3). p.108-109 Mark
- C3
- conference
Chromosome X polysomy is associated with increased androgen receptor expression in epithelial cells and reduced expression in stromal cells in treatment-naive prostate cancer
Charles Van Praet UGent, Filip Poelaert UGent, STEPHANIE VERSCHUERE, Louis Libbrecht, Marleen Praet, Sylvie Rottey UGent, Simon Van Belle UGent, Karel Decaestecker UGent, Tom Claeys and Nicolaas Lumen UGent (2014) EUROPEAN UROLOGY SUPPLEMENTS. 13(5). p.104-104 Mark
- A1
- journalArticle
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Karel Decaestecker UGent, Gert De Meerleer UGent, Bieke Lambert UGent, Louke Delrue, VALERIE FONTEYNE, Tom Claeys, Filip De Vos UGent, Wouter Huysse, Arne Hautekiet, Gaethan Maes, et al. (2014) RADIATION ONCOLOGY. 9. Mark
2012
- A1
- journalArticle
Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study
Harmen Reyngoudt UGent, Tom Claeys, Leslie Vlerick UGent, Stijn Verleden, Marjan Acou UGent, Karel Deblaere UGent, Yves De Deene UGent, Kurt Audenaert UGent, Ingeborg Goethals UGent and Eric Achten UGent (2012) EUROPEAN JOURNAL OF RADIOLOGY. 81(3). p.e223-e231 Mark
2011
- C3
- conference
Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: A 1H-MRS study
Harmen Reyngoudt UGent, Tom Claeys, Leslie Vlerick UGent, Stijn Verleden, Marjan Acou UGent, Karel Deblaere UGent, Yves De Deene UGent, Kurt Audenaert UGent, Ingeborg Goethals UGent and Eric Achten UGent (2011) ISMRM Benelux Chapter, 3rd Annual meeting, Abstracts. p.98-98 Mark
- C3
- conference
Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study
Harmen Reyngoudt UGent, Tom Claeys, Leslie Vlerick UGent, Stijn Verleden, Marjan Acou UGent, Karel Deblaere UGent, Yves De Deene UGent, Kurt Audenaert UGent, Ingeborg Goethals UGent and Eric Achten UGent (2011) 19th annual meeting & exhibition : International Society for Magnetic Resonance in Medicine (ISMRM - 2011), Abstracts. p.421-421 Mark